Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 52 | 51 | 0 | 0 | 0 |
| Gross Profit | 50 | 51 | N/A | N/A | 0 |
| Operating Expenses | 1,160 | 677 | 880 | 1,089 | 940 |
| Operating Income | -1,108 | -626 | -880 | -1,089 | -940 |
| Interest Expense | 10 | 0 | 0 | 0 | 0 |
| Other Income | -12 | 0 | 0 | -24 | 10 |
| Pre-tax Income | -1,130 | -626 | -880 | -1,113 | -930 |
| Net Income Continuous | -1,114 | -626 | -880 | -1,113 | -915 |
| Net Income | $-1,114 | $-626 | $-880 | $-1,113 | $-915 |
| EPS Basic Total Ops | -524.48 | -262.24 | -349.65 | -437.06 | -349.65 |
| EPS Basic Continuous Ops | -530.48 | -255.28 | -360.94 | -466.67 | -351.92 |
| EPS Diluted Total Ops | -524.48 | -262.24 | -349.65 | -437.06 | -349.65 |
| EPS Diluted Continuous Ops | -530.48 | -255.28 | -360.94 | -466.67 | -351.92 |
| EBITDA(a) | $-1,001 | $-542 | $-786 | $-995 | $-840 |